BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

BioQ and ALERE Medical Incorporated to Provide At-Home Biometric Screening Tests to Employees


12/3/2008 9:05:04 AM

SANTA BARBARA, Calif., Dec. 2 /PRNewswire/ -- BioIQ, the leader in consumer-friendly health testing products and services, and Alere(R), who provides services that include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions to health plans, employers, and government agencies, will work together to supply BioIQ's home-test kits and online reporting tools as part of Alere's Personal Health Solutions.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080826/LATU074)

"In today's increasingly virtual world, more employees are working remotely, either from home or satellite locations," said Dr. Ron Geraty, CEO of Alere. "By identifying risk factors early, we can in many cases minimize the impact of conditions such as diabetes, heart disease, hypertension and obesity. With this expanded Screening Services offering, Alere will be able to reach both employees and dependents more effectively."

As part of this workplace-wellness initiative, participants of Alere's Screening Services Programs will order BioIQ test kits via a secure website, which are then mailed to their homes. Each kit includes instructions for drawing a small blood sample through a simple finger-prick method and mailing it to a certified laboratory for analysis. Measurements include high-density lipoprotein (HDL), low-density lipoprotein (LDL), total cholesterol, triglycerides, hemoglobin/A1c, and fasting glucose. A single-sign-on login process will enable Alere participants to seamlessly access BioIQ's enrollment and lab results pages via secure personal accounts. In addition, the results from the BioIQ tests will be automatically loaded into each participant's Health & Productivity Assessment and Personal Health Record, which are part of Alere's Wellness Solutions.

"BioIQ adds to Alere's current on-site and in-home screening offering, enabling them to screen more people and more effectively identify health risks," said Justin Bellante, CEO at BioIQ. "Biometric testing leads to more effective interventions, treatment, and follow-up."

About BioIQ

BioIQ (www.bioiq.com) is a healthcare information technology company that develops and markets medical diagnostic solutions through corporate, institutional and direct-to-consumer channels. The company's affordable and innovative home test kits are commonly used to monitor or screen for diabetes, cancer, heart disease, kidney disease, thyroid disorder, osteoporosis, and other chronic health conditions.

About Alere

Alere is a member of the Inverness Medical Innovations (www.invernessmedical.com) family of companies and represents the union of Alere Medical, ParadigmHealth and Matria(R) Healthcare. Alere is the Latin verb meaning "to care for" or "to support". Services include wellness, healthy living, productivity improvement and complex care management as well as case management of acute and catastrophic conditions and high-risk pregnancy and NICU management. In addition, in-home diagnostics monitoring devices address the need for the daily monitoring of medium- and high-risk patients. Inverness Medical Innovations is a global leader in rapid point-of-care diagnostics, cardiology, oncology, women's health and health management services. More information can be found about Alere at www.alere.com.

(C) 2008 Inverness Medical. All rights reserved. Alere and Matria are trademarks of the Inverness Medical group of companies.



CONTACT: David Baum of BioIQ, +1-805-563-1309, dbaum@bioiq.com

Web site: http://www.alere.com/
http://www.bioiq.com/
http://www.invernessmedical.com/



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES